Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.77 |
| ▸ | P4HA1 | P13674 | 3/20 | 0.59 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.59 |
| ▸ | MIF | P14174 | 1/20 | 0.57 |
| ▸ | GABRP | O00591 | 1/20 | 0.55 |
| ▸ | GABRD | O14764 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.55 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.55 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.55 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.55 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.55 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.55 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29693605 | 0.87 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL147705 | 0.87 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11505192 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL11504736 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11504865 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11504782 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL11504397 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL11504738 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| Hydrogen Sulfide SCHEMBL22616567 | 0.85 | ALDH1A1 (0.96) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL24602906 | 0.83 | ALDH1A1 (0.71) | ALDH1A1CYP1A2CYP2C9HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1461028-A4 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | UNIV CALIFORNIA (US) | 2007-07-25 | — | — | EP | claimed |
| WO-2004098506-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-11-18 | — | — | WO | claimed |
| EP-1461028-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | The Regent of the University of California (US) | 2004-09-29 | — | — | EP | claimed |
| US-20030229062-A1 | Treatments for age-related macular degeneration (AMD) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-12-11 | — | — | US | claimed |
| US-20030162758-A1 | Treatment for age-related macular degeneration (AMD) | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-08-28 | — | — | US | claimed |
| WO-2003049685-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-06-19 | — | — | WO | claimed |
| US-20100047330-A1 | TREATMENT FOR DARK ADAPTATION | THE REGENTS OF THE UNIVERSTIY OF CALIFORNIA | 2010-02-25 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| US-7470660-B2 | Treatment for dark adaptation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470659-B2 | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-12-30 | — | — | US | disclosed |
| EP-1461028-A4 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | UNIV CALIFORNIA (US) | 2007-07-25 | — | — | EP | disclosed |
| US-20050282750-A1 | Treatment for dark adaptation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-12-22 | — | — | US | disclosed |
| WO-2005091909-A2 | METHODS TO INCREASE REVERSE CHOLESTEROL TRANSPORT IN THE RETINAL PIGMENT EPITHELIUM (RPE) AND BRUCH’S MEMBRANE (BM) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-10-06 | — | — | WO | disclosed |
| US-20040266663-A1 | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and bruch's membrane (BM) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-12-30 | — | — | US | disclosed |
| WO-2004098506-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-11-18 | — | — | WO | disclosed |
| EP-1461028-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | The Regent of the University of California (US) | 2004-09-29 | — | — | EP | disclosed |
| US-20030229062-A1 | Treatments for age-related macular degeneration (AMD) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-12-11 | — | — | US | disclosed |
| US-20030162758-A1 | Treatment for age-related macular degeneration (AMD) | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-08-28 | — | — | US | disclosed |
| WO-2003049685-A2 | TREATMENT FOR AGE-RELATED MACULAR DEGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-06-19 | — | — | WO | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |